Top Story

Atherosclerosis risk increased among men with diabetes, low testosterone

October 17, 2014

A greater risk for developing atherosclerosis is found among middle-aged men with low testosterone and type 2 diabetes, according to recent study findings published in The Journal of Clinical Endocrinology & Metabolism.

“Our study indicates a strong association between low testosterone concentration and the severity of atherosclerotic plaques as well as other key atherosclerotic markers in middle-aged men with type 2 diabetes,” Javier Mauricio Farias, MD, of the Hospital Universitario Sanatorio Guemes in Buenos Aires, said in a press release. “The results of our study advance our understanding of the interplay between low testosterone and cardiovascular disease in patients with diabetes.”

Meeting News Coverage

Biguanides, liraglutide reduced CVD risk in type 2 diabetes

September 24, 2014
Patients with type 2 diabetes treated with biguanides and liraglutide have a reduced risk for ischemic heart disease, heart failure and stroke, according to research…
figure Meeting News Coverage

Higher plasma levels linked to CV complications in type 1 diabetes

September 18, 2014
Cardiovascular complications are associated with higher plasma levels in patients with type 1 diabetes, according to a presenter at the 50th European Association for the…
In the Journals

Age, diabetes duration increases risk for macrovascular complications

September 12, 2014
For patients with type 2 diabetes, macrovascular events and death are associated with age or age at diagnosis and diabetes duration, according to research published in…
CME
figure

Risk Management in the Cardiovascular Disease Arena: Focus on Glycemic Control

This activity is supported by an educational grant from Genentech.

Among the multiple comorbidities and complications that are associated with type 2 diabetes mellitus (T2DM)…
More »
CME
figure

Lipid Forum II Highlights

This activity is supported by an educational grant from Genentech.

Risk stratification and appropriate therapies for various dyslipidemias remain difficult concepts for practitioners…
More »

Filter By:

In the Journals

Gestational diabetes may be marker for early atherosclerosis

March 12, 2014
History of gestational diabetes appears to be a marker for early atherosclerosis regardless of pre-pregnancy obesity in women with no subsequent…
In the Journals

Gestational diabetes may be marker for early atherosclerosis

Cardiology Today, April 2014
History of gestational diabetes appears to be a marker for early atherosclerosis regardless of pre-pregnancy obesity in women with no subsequent…
In the Journals

Novel therapy lowered LDL in patients with diabetes, hypercholesterolemia

March 7, 2014
ETC-1002, a novel agent in development by Esperion Therapeutics, lowered LDL levels by nearly 43% in patients with type 2 diabetes and…
In the Journals

Novel therapy lowered LDL in patients with diabetes, hypercholesterolemia

Cardiology Today, April 2014
ETC-1002, a novel agent in development by Esperion Therapeutics, lowered LDL levels by nearly 43% in patients with type 2 diabetes and…
FDA approvals Perspective

FDA approves Myalept for treatment of lipodystrophy

February 25, 2014
The FDA today approved metreleptin, in combination with diet, for the treatment of complications of leptin deficiency in patients with congenital…

FDA to review heart failure risk associated with saxagliptin

February 11, 2014
The FDA requested additional clinical trial data for saxagliptin due to potential heart failure risks, according to an announcement released…
FDA News

FDA to review heart failure risk associated with saxagliptin

Cardiology Today, April 2014
The FDA requested additional clinical trial data for saxagliptin due to potential heart failure risks, according to an announcement released…

CVS plans to stop all tobacco sales

February 6, 2014
CVS Caremark has announced that it will eliminate the sale of cigarettes and other tobacco products in all of its US pharmacies by October.There are…
figure CME

Risk Management in the Cardiovascular Disease Arena: Focus on Glycemic Control

February 1, 2014 Expires: 2/1/2015
Among the multiple comorbidities and complications that are associated with type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD) is the…
Meeting News Coverage

ACC announces late-breaking clinical trials

January 31, 2014
The American College of Cardiology has announced the line-up of late-breaking clinical trials scheduled for presentation at its Annual Scientific…
More Headlines »